NAV: 13 Jan 2025 | ₹19.58 |
Min. SIP amount | Not Supported |
Rating | 2 |
Fund size | ₹162.05Cr |
6M | 1Y | 3Y | All | |
---|---|---|---|---|
Fund returns | NA | 20.2% | 14.9% | 17.3% |
Category average | NA | 28.1% | 17.3% | NA |
Rank with in category | NA | 14 | 11 | NA |
Name | Sector | Instrument | Assets |
---|---|---|---|
Sun Pharmaceutical Industries Ltd. | Healthcare | Equity | 13.13% |
Cipla Ltd. | Healthcare | Equity | 6.19% |
Max Healthcare Institute Ltd. | Healthcare | Equity | 5.85% |
Divi's Laboratories Ltd. | Healthcare | Equity | 5.67% |
Dr. Reddy's Laboratories Ltd. | Healthcare | Equity | 5.39% |
Apollo Hospitals Enterprise Ltd. | Healthcare | Equity | 5.28% |
Eli Lilly And Co | Healthcare | Forgn. Eq | 4.99% |
Lupin Ltd. | Healthcare | Equity | 3.59% |
Johnson & Johnson Ltd. | Healthcare | Forgn. Eq | 2.87% |
Novo Nordisk A/S - ADR | Healthcare | Forgn. Eq | 2.65% |
Torrent Pharmaceuticals Ltd. | Healthcare | Equity | 2.59% |
Aurobindo Pharma Ltd. | Healthcare | Equity | 2.56% |
AbbVie Inc | Healthcare | Forgn. Eq | 2.49% |
Fortis Healthcare Ltd. | Healthcare | Equity | 2.49% |
Merck & Co Inc (US) | Healthcare | Forgn. Eq | 1.98% |
Mankind Pharma Ltd. | Healthcare | Equity | 1.97% |
Zydus Lifesciences Ltd. | Healthcare | Equity | 1.87% |
Glenmark Pharmaceuticals Ltd. | Healthcare | Equity | 1.66% |
Ipca Laboratories Ltd. | Healthcare | Equity | 1.65% |
Novartis AG | Healthcare | ADS/ADR | 1.61% |
Abbott Laboratories | Healthcare | Forgn. Eq | 1.59% |
Thermo Fisher Scientific Inc. | Healthcare | Forgn. Eq | 1.56% |
Laurus Labs Ltd. | Healthcare | Equity | 1.53% |
Intuitive Surgical Inc. (USA) | Healthcare | Forgn. Eq | 1.48% |
Syngene International Ltd. | Healthcare | Equity | 1.31% |
Danaher Corporation | Healthcare | Forgn. Eq | 1.23% |
Biocon Ltd. | Healthcare | Equity | 1.17% |
Amgen Inc. (USA) | Healthcare | Forgn. Eq | 1.17% |
Stryker Corp | Healthcare | Forgn. Eq | 1.03% |
Suven Pharmaceuticals Ltd. | Healthcare | Equity | 1.02% |
Ajanta Pharma Ltd. | Healthcare | Equity | 1.02% |
Gland Pharma Ltd. | Healthcare | Equity | 0.99% |
JB Chemicals & Pharmaceuticals Ltd. | Healthcare | Equity | 0.93% |
Vertex Pharmaceuticals Inc. (USA) | Healthcare | Forgn. Eq | 0.93% |
Gilead Sciences Inc. (USA) | Healthcare | Forgn. Eq | 0.89% |
Dr. Lal Pathlabs Ltd. | Healthcare | Equity | 0.87% |
Medtronic | Healthcare | Forgn. Eq | 0.86% |
Glaxosmithkline Pharmaceuticals Ltd. | Healthcare | Equity | 0.80% |
Global Health Ltd. | Healthcare | Equity | 0.67% |
Regeneron Pharmaceuticals Inc | Healthcare | Forgn. Eq | 0.63% |
Pfizer Ltd. | Healthcare | Equity | 0.56% |
Becton Dickinson And Co | Healthcare | Forgn. Eq | 0.49% |
Agilent Technologies Inc | Healthcare | Forgn. Eq | 0.31% |
Iqvia Holdings | Healthcare | Forgn. Eq | 0.28% |
Illumina Inc. (USA) | Healthcare | Forgn. Eq | 0.18% |
Grail Inc | Healthcare | Forgn. Eq | 0.00% |
Inclusive of GST
Nil
0.005% (from July 1st, 2020)
Returns are taxed at 20%, if you redeem before one year. After 1 year, you are required to pay LTCG tax of 12.5% on returns of Rs 1.25 lakh+ in a financial year.
Min. for 1st investment | ₹100 |
Min. for 2nd investment onwards | ₹100 |
Min. for SIP | Not Supported |